Article Cited by others


Selective androgen receptor modulators for the treatment of late onset male hypogonadism

Coss Christopher C, Jones Amanda, Hancock Michael L, Steiner Mitchell S, Dalton James T

Year : 2014| Volume: 16| Issue : 2 | Page no: 256-261

   This article has been cited by
1 Combined Effects of Exercise and Phytoanabolic Extracts in Castrated Male and Female Mice
Jerônimo P. Martins,Lucia C. Silva,Matheus S. Nunes,Gabriel Rübensam,Jarbas R. Oliveira,Rodrigo B. M. Silva,Maria M. Campos
Nutrients. 2021; 13(4): 1177
[Pubmed]  [Google Scholar] [DOI]
2 A selective androgen receptor modulator SARM-2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys
Megumi Morimoto,Masuo Yamaoka,Takahito Hara
Pharmacology Research & Perspectives. 2020; 8(1)
[Pubmed]  [Google Scholar] [DOI]
3 Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor
Sophia G Liva,Yu-Chou Tseng,Anees M Dauki,Michael G Sovic,Trang Vu,Sally E Henderson,Yi-Chiu Kuo,Jason A Benedict,Xiaoli Zhang,Bryan C Remaily,Samuel K Kulp,Moray Campbell,Tanios Bekaii-Saab,Mitchell A Phelps,Ching-Shih Chen,Christopher C Coss
EMBO Molecular Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism
Joshua A Earl,Edward D Kim
Expert Review of Endocrinology & Metabolism. 2019; 14(3): 157
[Pubmed]  [Google Scholar] [DOI]
5 International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management
Elsa Dent,J. E. Morley,A. J. Cruz-Jentoft,H. Arai,S. B. Kritchevsky,J. Guralnik,J. M. Bauer,M. Pahor,B. C. Clark,M. Cesari,J. Ruiz,C. C. Sieber,M. Aubertin-Leheudre,D. L. Waters,R. Visvanathan,F. Landi,D. T. Villareal,R. Fielding,C. W. Won,O. Theou,F. C. Martin,B. Dong,J. Woo,L. Flicker,L. Ferrucci,R. A. Merchant,L. Cao,T. Cederholm,S. M. L. Ribeiro,L. Rodríguez-Mañas,S. D. Anker,J. Lundy,L. M. Gutiérrez Robledo,I. Bautmans,I. Aprahamian,J. M. G. A. Schols,M. Izquierdo,B. Vellas
The journal of nutrition, health & aging. 2018;
[Pubmed]  [Google Scholar] [DOI]
6 Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK-11 for doping control purposes
Mario Thevis,Thomas Piper,Josef Dib,Andreas Lagojda,Dirk Kühne,Lars Packschies,Hans Geyer,Wilhelm Schänzer
Rapid Communications in Mass Spectrometry. 2017; 31(14): 1175
[Pubmed]  [Google Scholar] [DOI]
7 Detection of SARMs in doping control analysis
Mario Thevis,Wilhelm Schänzer
Molecular and Cellular Endocrinology. 2017;
[Pubmed]  [Google Scholar] [DOI]
8 Enclomiphene citrate for the treatment of secondary male hypogonadism
Katherine M. Rodriguez,Alexander W. Pastuszak,Larry I. Lipshultz
Expert Opinion on Pharmacotherapy. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
9 Phase II drugs currently being investigated for the treatment of hypogonadism
Emeka Udedibia,Jed Kaminetsky
Expert Opinion on Investigational Drugs. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]


Read this article